News & Resouces

The Latest News from OACS Ireland

Sodium Valproate “Epilim” Campaign Update

By wpengine | December 5, 2022

Last updated:05/12/2022 We and our colleagues in Epilepsy Ireland are pleased to inform our members and supporters that there have been two positive developments recently regarding our ongoing joint campaign surrounding Sodium Valproate (Epilim) updates is as follows: The Disability…

More . . .

OACS Ireland Annual Report 2021

By wpengine | November 24, 2022

Chairs Opening Remarks 2021 was another important year as we sought to progress the Inquiry into the historical licensing and use of sodium valproate (Epilim) in Ireland which was promised by the Minister for Health in November 2020. At the…

More . . .

Supporting #MedSafetyWeek 2022

By wpengine | November 7, 2022

Global campaign to promote reporting side effects from medicines. Takes place from Monday 7 November to Sunday 13 November 2022.  OACS Ireland will be supporting the HPRA with their part in the seventh annual #MedSafetyWeek, a global week-long social media campaign to raise…

More . . .

Crucial Update on Topiramate (Topamax) for women with epilepsy and other conditions of childbearing potential.

By wpengine | October 24, 2022

Updated the 24/10/2022 During the summer, a new piece of research suggested that the potential neurodevelopmental impacts associated with the anti-seizure medication (ASM) Topiramate (Topamax) if prescribed during pregnancy may be more significant than previously thought. The paper led to…

More . . .

OACS Ireland and Epilepsy Ireland meet with the Minister for Health

By Karen | September 7, 2022

A spokesman for OACS Ireland and Epilepsy Ireland, supporting the families, said the meeting took place on Tuesday. “The meeting was a frank exchange of views on the latest proposed terms of reference for the inquiry, between the patient groups…

More . . .

A Irish Independent Exclusive. The stories of the families affected by Sodium Valproate (Epilim) in Ireland…

By wpengine | August 29, 2022

The Irish Independent have published a documentary featuring women who were prescribed Sodium Valproate (Epilim) during pregnancy. The documentary discusses how this has affected their life and the lives of their children. The feature is a powerful piece which highlights…

More . . .

OACS Ireland & Epilepsy Ireland to meet with Minister for Health regarding Epilim (Sodium Valproate) Inquiry

By wpengine | August 10, 2022

Last Updated: Wed, 10/08/2022 OACS Ireland & Epilepsy Ireland will be meeting with the Minister for Health regarding the proposed Terms of Reference into the historical licensing and prescribing of Epilim (Sodium Valproate). This drug can cause a range of disabilities…

More . . .

New study published on neurodevelopmental outcomes on prenatal exposure to AEDs

By wpengine | July 12, 2022

A new study has found that the potential neurodevelopmental impacts associated with the anti-epileptic drug (AED) Topiramate (Topamax) if prescribed during pregnancy may be more significant than previously thought. The study also found increased risks associated with other AEDs when…

More . . .

Sodium Valproate Inquiry Update.

By wpengine | June 8, 2022

Last Updated: Wed,08/06/2022 – 07:43 Epilepsy Ireland and OACS Ireland met with Department of Health officials yesterday to discuss the establishment of the long-awaited Sodium Valproate inquiry. There was an open and honest discussion about the delays in establishing the inquiry…

More . . .

Sodium Valproate Inquiry Update.

By wpengine | June 3, 2022

OACS Ireland and Epilepsy Ireland have received an invitation from the Minister for Health to meet in order to discuss the establishment of the inquiry into the historical licensing and prescribing of Sodium Valproate in Ireland. We have accepted this…

More . . .

Videos / Media

OACS Ireland: The Story So Far

Public Hearing on Valproate

Epilim (Sodium Valproate): For Patients*

Epilim (Sodium Valproate): For Hospital Doctors*

Epilim (Sodium Valproate): For Neurologists & Psychiatrists*

Epilim (Sodium Valproate): For GPs*

*The Medication Safety Minute Team in conjunction with Dr Colin Doherty, Epileptologist in St. James’s Hospital (SJH), have produced a series of 4 videos to highlight the risks associated with sodium valproate medicines if taken during pregnancy. Each of the videos highlights key points in relation to the management of the issue from a different perspective − that of the patient, the hospital doctor, the specialist (neurologist or psychiatrist), and the GP, respectively. These videos were released during National Epilepsy Week which aims to raise awareness Epilim (Sodium Valproate) in pregnancy.